Pacira BioSciences (PCRX) Debt Ratio (2010 - 2026)

Pacira BioSciences' Debt Ratio history runs 15 years deep, the most recent figure standing at 0.3 for Q1 2026.

• In Q1 2026, Debt Ratio rose 59.0% year-over-year to 0.3; the TTM figure through Mar 2026 stood at 0.3 (up 59.0% YoY), while the FY2025 annual figure was 0.29, down 21.91% from the prior year.
• Debt Ratio was 0.3 for Q1 2026 at Pacira BioSciences, up from 0.29 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.38 in Q4 2024 to a low of 0.07 in Q2 2024.
• Historically, Debt Ratio has averaged 0.18 across 5 years, with a median of 0.19 in 2022.
• The sharpest annual moves came in 2023 and 2024: Debt Ratio plunged 61.21% in 2023, then surged 378.98% in 2024.
• A 5-year view of Debt Ratio shows it stood at 0.17 in 2022, then plunged by 53.55% to 0.08 in 2023, then soared by 378.98% to 0.38 in 2024, then decreased by 21.91% to 0.29 in 2025, then increased by 3.39% to 0.3 in 2026.
• The last three Debt Ratio figures came in at 0.3 (Q1 2026), 0.29 (Q4 2025), and 0.29 (Q3 2025), per Business Quant data.